Search
Sumario de resultados
TIpos de contenido
Fecha
-
New
#NewMember | "AseBio has been a helping hand in gaining visibility and attracting resource...
Meet PALMEERA, our new partner. We talked to Jorge González Cánovas, the company's Operations Director.
-
Offer
Project Manager
-
Company
BIOGA
-
Event
Industria Biotech
-
Logo Quibim
CompanyQuibim SL
-
-
-
-
Project
European Climate Pact
-
New
BIOLAN awarded as "SME of the year of Bizkaia 2022" in the VI Edition of the SME of the ye...
The VI edition of the SME of the year awards was held in Bilbao on 18 July. These awards recognise essential aspects of the contribution to society and the economy of SMEs, which make up 99.8% of the
-
New
El Ayuntamiento de Carboneras y Endesa testigos del avance de las obras de la planta de mi...
ALGAVILLAGE, proyecto conjunto de la compañía británica Firglas y la biotecnológica almeriense Biorizon Biotech, avanza firme con la construcción de su planta de microalgas en Carboneras (Almería)
-
New
ORYZON reports results and corporate update for half-year ending June 30, 2022
Oryzon invests $8.1 million in R&D in the first half 2022
-
New
ORYZON collaborates with the CMT Research Foundation in the US
To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth disease CMTRF to provide funding for in vivo efficacy tests in CMT preclinical model
-
Company
ADIC-IIC
-
New
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle t...
GENESIS Biomed will be the managing entity of the vehicle
-
New
pbserum enzymes continue to expand in the Middle East
This new launch follows a trend of expansion of the Spanish brand after its success in Europe and the Americas, with a significant presence in countries such as Mexico, Colombia and Argentina. Today
-
New
CTIS for sponsors of clinical trials
PVPHARM, a leading company in specialized pharmacovigilance and clinical safety services, has a group of experts that can manage CTIS on behalf of any clinical trial sponsor, and related tasks
-
New
ZYMVOL lands in Boston, expands towards health-related enzyme projects
The company plans to continue pushing forward the development of in silico enzyme discovery and design projects in the United States, especially in the area of the Life Sciences
-
Event
AusBioInvest 2022
-
Event
AusBiotech 2022
-
New
ORYZON enters cooperative research and development agreement (CRADA) with U.S. National Ca...
Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different hematological and solid tumors